Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis. - Wikidata - wikimedia - TriplyDB

Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.

Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.

http://www.wikidata.org/entity/Q43718510

about

Comparison of the King's and MiToS staging systems for ALS.Quantifying disease progression in amyotrophic lateral sclerosis.Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study.Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.Use of biomarkers in ALS drug development and clinical trials Autoimmune Aspects of Neurodegenerative and Psychiatric Diseases: A Template for Innovative Therapy.Inflammation in neurodegenerative diseases--an update.Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS).Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort Non-neuronal Cells in ALS: Role of Glial, Immune cells and Blood-CNS Barriers.Increased Incidence of Amyotrophic Lateral Sclerosis in Polymyositis: A Nationwide Cohort Study.Neurofilaments in CSF As Diagnostic Biomarkers in Motor Neuron Disease: A Meta-Analysis.TDP-43 and Cytoskeletal Proteins in ALS.Neurofilament light as an immune target for pathogenic antibodies.Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis.Amyotrophic Lateral Sclerosis: An Aging-Related Disease Paraneoplastic neuronal intermediate filament autoimmunity Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry

P2860

Q33659132-CEFDCEC3-0387-487F-BC8C-5B2E7BB4289F Q35008605-BB99D735-D534-41F4-A5C6-8F873EA7B2D7 Q35550715-5D7BFFC5-0D5B-4E95-8D61-53881959B80A Q35686186-10E31EA1-F736-4335-A6A7-409C80D82040 Q36733981-2A8B991E-E05B-4108-8834-891AD3BC59CC Q37736100-16EE40AE-C176-480B-82F5-9EE1B835989A Q38170472-61370667-3DA0-4DA7-A796-844F90ADAB3C Q38232360-69CA6F95-A728-4947-B3B7-DBF959D6FFA0 Q38262690-E7922FDE-ED18-42B6-9F7F-23F7C0FB9005 Q38312121-69C29431-C882-4FE8-A50B-4BE6AC6B22E1 Q38683234-51015E47-CBED-44FC-A8FC-F1F95BB83D56 Q38701186-4FABF4C9-CA19-4C0C-B91B-F229D1ED1130 Q38813077-C1DDBC2F-8840-4292-8B9D-540BF2AD2E6B Q39103639-7AC76537-9354-452B-A12F-B8B2F3C3E144 Q39279950-BE6502E1-2E34-4AFD-8719-09DA0C62289E Q40130553-1EC0274A-745A-418A-A1F5-A1A17DC2A942 Q52688574-3347C2F0-83E8-4E9D-B770-E211B4488D13 Q56839346-5AD419E9-9794-4C96-BDDA-DA2CC824F9A4 Q57040096-038E8889-CA39-4BD0-8A6D-89028F461C9A Q57498761-F673F6F4-92A7-43D0-9B95-6ABD13954123 Q58703232-68414CAC-ACEC-41EF-A409-A154C409C1F1

P2860

Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.

http://www.wikidata.org/entity/Q43718510

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Immune reactivity to neurofila ...... amyotrophic lateral sclerosis.

@en

Immune reactivity to neurofila ...... amyotrophic lateral sclerosis.

@nl

type

label

Immune reactivity to neurofila ...... amyotrophic lateral sclerosis.

@en

Immune reactivity to neurofila ...... amyotrophic lateral sclerosis.

@nl

prefLabel

Immune reactivity to neurofila ...... amyotrophic lateral sclerosis.

@en

Immune reactivity to neurofila ...... amyotrophic lateral sclerosis.

@nl

P1433

Q43718510-91CBA86D-5B34-4BAC-94D6-2A4933E9EE79

P1476

Q43718510-E9D5642D-70C2-475E-A058-C928FC80DD44

P2093

Q43718510-0B4261AF-8D52-40A5-BD26-E553D724CD46

Q43718510-210F0C87-87B9-43B9-88C4-AA7F8E725CDA

Q43718510-28556B60-CC8E-4690-A8CB-4F6FB7FA64CA

Q43718510-2AAEAC11-81BB-4AD0-8DD4-AED62D32F8E0

Q43718510-2FF5B485-9CDD-42D9-BBAB-5EB89248F1A4

Q43718510-98BBBF9F-77CF-41F0-AF0E-469273FC61B5

Q43718510-B66055D8-BC4E-4D0F-B27C-C6215998B3C3

P2860

Q43718510-0D8890E4-AF58-45AD-955F-5E2C6A9326D8

Q43718510-40248CA8-9DFC-4517-A7C3-51BC019A0CC4

Q43718510-5DD8144E-FAC5-4C83-8820-F7C6DEBCA507

Q43718510-82C527EC-1499-40AF-B9F1-091076E3E4DD

Q43718510-A3F5B2F7-D7A1-482C-9480-55863302A033

Q43718510-A91CA491-CD5D-4239-9574-933D55793C55

Q43718510-AA239AE6-9E49-45E8-BD59-947B5F6A5A28

Q43718510-AB35A0A8-EE09-4DD5-B62C-1ED013380C39

Q43718510-B0E337CA-9B5A-4F7D-B440-294177A3CC93

Q43718510-B639B0DA-A58A-4A4C-81CC-23EE36110A1B

P304

Q43718510-6CF39274-6FD5-4523-99E0-31589693F54E

P31

Q43718510-0E3C751A-E54D-4965-B788-8873122EA7B8

P356

Q43718510-9E623316-AC40-4B13-A27D-F50AA836809D

P407

Q43718510-124DBAEB-F064-4C5D-87DE-6C808DCB9FBE

P433

Q43718510-9F5FDFC2-1D3A-4552-B827-7F8A9481803A

P478

Q43718510-E1C40F7C-9ADC-4831-BE0F-82FC51FC4DF2

P50

Q43718510-8C1E07A1-B786-457A-86F2-D155FBD50328

Q43718510-EC220450-255F-47C6-9D60-9D07B55C93D1

P577

Q43718510-95D04A41-1583-421F-A2D3-5039651E82C8

P5875

Q43718510-E6728CAA-604B-48EE-B8F1-72150387EF04

P698

Q43718510-9C4ECCC6-CBEB-49B6-99E0-7C0221B2A4CD

P921

Q43718510-E62CC493-7CD8-4AC8-9C39-96E30D094565

P356

JNNP-2013-305494

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Immune reactivity to neurofila ...... amyotrophic lateral sclerosis.

@en

P2093

Andrea Malaspina

http://www.w3.org/2001/XMLSchema#string

Baukje J van der Star

http://www.w3.org/2001/XMLSchema#string

David Baker

http://www.w3.org/2001/XMLSchema#string

Fabiola Puentes

http://www.w3.org/2001/XMLSchema#string

Jens Kuhle

http://www.w3.org/2001/XMLSchema#string

Joanne Topping

http://www.w3.org/2001/XMLSchema#string

Sandra Amor

http://www.w3.org/2001/XMLSchema#string

P2860

Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS

Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.

Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.

A proposed staging system for amyotrophic lateral sclerosis.

Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis.

Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group.

Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis.

Decreased level of 5-methyltetrahydrofolate: a potential biomarker for pre-symptomatic amyotrophic lateral sclerosis.

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.

Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.

P304

274-278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP-2013-305494

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Gavin Giovannoni

P577

2013-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257206706

http://www.w3.org/2001/XMLSchema#string

P698

24078718

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis